Journal of Parkinson's Disease October 2021LikeFollowShareThe Compound ATH434 Prevents Alpha-Synuclein Toxicity in a Murine Model of Multiple System Atrophyhttps://journals.sagepub.com/doi/10.3233/JPD-212877Share your feedbackQuestions (0)Post questionYour question will be sent privately to Alterity Therapeutics. The company may choose to make this question public.Start the conversationAsk Alterity Therapeutics a question about this update.DiscoverShare your feedbackDiscover